Immunotherapy
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
30
NCT05145569
Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer
Phase: Phase 2
Role: Collaborator
Start: May 10, 2024
Completion: Jan 31, 2028
NCT07049328
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 16, 2025
Completion: Dec 15, 2026
Loading map...